S&P 500   4,590.14 (+0.49%)
DOW   36,175.98 (+0.63%)
QQQ   389.33 (+0.13%)
AAPL   190.96 (+0.53%)
MSFT   372.88 (-1.59%)
META   324.19 (-0.90%)
GOOGL   131.44 (-0.82%)
AMZN   146.58 (+0.34%)
TSLA   237.40 (-1.12%)
NVDA   469.78 (+0.44%)
NIO   7.17 (-1.38%)
BABA   73.35 (-2.04%)
AMD   120.66 (-0.41%)
T   16.64 (+0.42%)
F   10.50 (+2.34%)
MU   75.88 (-0.32%)
CGC   0.59 (+5.29%)
GE   123.23 (+1.17%)
DIS   92.18 (-0.55%)
AMC   6.77 (+1.80%)
PFE   29.22 (-4.10%)
PYPL   58.97 (+2.36%)
XOM   103.81 (+1.04%)
S&P 500   4,590.14 (+0.49%)
DOW   36,175.98 (+0.63%)
QQQ   389.33 (+0.13%)
AAPL   190.96 (+0.53%)
MSFT   372.88 (-1.59%)
META   324.19 (-0.90%)
GOOGL   131.44 (-0.82%)
AMZN   146.58 (+0.34%)
TSLA   237.40 (-1.12%)
NVDA   469.78 (+0.44%)
NIO   7.17 (-1.38%)
BABA   73.35 (-2.04%)
AMD   120.66 (-0.41%)
T   16.64 (+0.42%)
F   10.50 (+2.34%)
MU   75.88 (-0.32%)
CGC   0.59 (+5.29%)
GE   123.23 (+1.17%)
DIS   92.18 (-0.55%)
AMC   6.77 (+1.80%)
PFE   29.22 (-4.10%)
PYPL   58.97 (+2.36%)
XOM   103.81 (+1.04%)
S&P 500   4,590.14 (+0.49%)
DOW   36,175.98 (+0.63%)
QQQ   389.33 (+0.13%)
AAPL   190.96 (+0.53%)
MSFT   372.88 (-1.59%)
META   324.19 (-0.90%)
GOOGL   131.44 (-0.82%)
AMZN   146.58 (+0.34%)
TSLA   237.40 (-1.12%)
NVDA   469.78 (+0.44%)
NIO   7.17 (-1.38%)
BABA   73.35 (-2.04%)
AMD   120.66 (-0.41%)
T   16.64 (+0.42%)
F   10.50 (+2.34%)
MU   75.88 (-0.32%)
CGC   0.59 (+5.29%)
GE   123.23 (+1.17%)
DIS   92.18 (-0.55%)
AMC   6.77 (+1.80%)
PFE   29.22 (-4.10%)
PYPL   58.97 (+2.36%)
XOM   103.81 (+1.04%)
S&P 500   4,590.14 (+0.49%)
DOW   36,175.98 (+0.63%)
QQQ   389.33 (+0.13%)
AAPL   190.96 (+0.53%)
MSFT   372.88 (-1.59%)
META   324.19 (-0.90%)
GOOGL   131.44 (-0.82%)
AMZN   146.58 (+0.34%)
TSLA   237.40 (-1.12%)
NVDA   469.78 (+0.44%)
NIO   7.17 (-1.38%)
BABA   73.35 (-2.04%)
AMD   120.66 (-0.41%)
T   16.64 (+0.42%)
F   10.50 (+2.34%)
MU   75.88 (-0.32%)
CGC   0.59 (+5.29%)
GE   123.23 (+1.17%)
DIS   92.18 (-0.55%)
AMC   6.77 (+1.80%)
PFE   29.22 (-4.10%)
PYPL   58.97 (+2.36%)
XOM   103.81 (+1.04%)

Evolent Health Stock Price, News & Analysis (NYSE:EVH)

$28.55
+0.75 (+2.70%)
(As of 12:02 PM ET)
Compare
Today's Range
$27.51
$28.64
50-Day Range
$23.63
$29.74
52-Week Range
$23.33
$36.70
Volume
161,778 shs
Average Volume
1.03 million shs
Market Capitalization
$3.28 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$45.50

Evolent Health MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.86 Rating Score
Upside/​Downside
63.7% Upside
$45.50 Price Target
Short Interest
Bearish
7.19% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.67mentions of Evolent Health in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$330,000 Sold Last Quarter
Proj. Earnings Growth
102.70%
From $0.37 to $0.75 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.91 out of 5 stars

Computer And Technology Sector

390th out of 603 stocks

Management Services Industry

5th out of 5 stocks


EVH stock logo

About Evolent Health Stock (NYSE:EVH)

Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, offers clinical and administrative solutions to payers and providers in the United States. The company operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology, cardiology, and musculoskeletal markets; physician-oriented total cost of care solutions; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.

EVH Stock Price History

EVH Stock News Headlines

Is Gold Really Boring?
Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks.
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Evolent Health: Evolent Announces Third Quarter 2023 Results
Evolent Health (EVH) Q3 2023 Earnings Call Transcript
Evolent Announces Third Quarter 2023 Results
A First Evaluation On Evolent Health
Truist Financial Keeps Their Hold Rating on Evolent Health (EVH)
Evolent Health, Inc. (NYSE:EVH): Are Analysts Optimistic?
See More Headlines
Receive EVH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evolent Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/02/2023
Today
12/01/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/28/2024

Industry, Sector and Symbol

Industry
Management services
Sub-Industry
N/A
Employees
5,100
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$45.50
High Stock Price Target
$59.00
Low Stock Price Target
$34.00
Potential Upside/Downside
+63.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.86
Research Coverage
7 Analysts

Profitability

Net Income
$-19,160,000.00
Pretax Margin
-9.19%

Debt

Sales & Book Value

Annual Sales
$1.35 billion
Cash Flow
$1.42 per share
Book Value
$9.53 per share

Miscellaneous

Free Float
111,166,000
Market Cap
$3.19 billion
Optionable
Optionable
Beta
1.44
The Best High-Yield Dividend Stocks for 2023 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. Seth Barrie Blackley (Age 44)
    Co-Founder, CEO & Director
    Comp: $1.79M
  • Mr. Dan McCarthy (Age 38)
    CEO of New Century Health & President
    Comp: $1.29M
  • Mr. John Paul JohnsonMr. John Paul Johnson (Age 39)
    Chief Financial Officer
    Comp: $994.22k
  • Mr. Jonathan David Weinberg J.D. (Age 55)
    Chief Legal Officer, General Counsel & Secretary
    Comp: $696.07k
  • Ms. Emily Rafferty (Age 40)
    Chief Operating Officer
  • Mr. Aammaad Shams (Age 39)
    Chief Accounting Officer
    Comp: $341.78k
  • Ms. Jessica Somers
    Senior Vice President of Corporate Development
  • Ms. Kali Beyah
    Chief People & Brand Officer
  • Dr. John Tam M.D.
    Chief Strategy Officer
  • Dr. Andrew Hertler M.D.
    Chief Medical Officer of New Century Health














EVH Stock Analysis - Frequently Asked Questions

Should I buy or sell Evolent Health stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Evolent Health in the last year. There are currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" EVH shares.
View EVH analyst ratings
or view top-rated stocks.

What is Evolent Health's stock price target for 2024?

7 equities research analysts have issued 1 year price objectives for Evolent Health's stock. Their EVH share price targets range from $34.00 to $59.00. On average, they predict the company's share price to reach $45.50 in the next twelve months. This suggests a possible upside of 63.7% from the stock's current price.
View analysts price targets for EVH
or view top-rated stocks among Wall Street analysts.

How have EVH shares performed in 2023?

Evolent Health's stock was trading at $28.08 on January 1st, 2023. Since then, EVH shares have decreased by 1.0% and is now trading at $27.79.
View the best growth stocks for 2023 here
.

When is Evolent Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 28th 2024.
View our EVH earnings forecast
.

How were Evolent Health's earnings last quarter?

Evolent Health, Inc. (NYSE:EVH) released its quarterly earnings data on Thursday, November, 2nd. The technology company reported $0.19 earnings per share for the quarter. The technology company earned $511.02 million during the quarter, compared to the consensus estimate of $508.21 million. Evolent Health had a negative net margin of 5.08% and a positive trailing twelve-month return on equity of 4.83%.

What ETFs hold Evolent Health's stock?
What is Seth Blackley's approval rating as Evolent Health's CEO?

12 employees have rated Evolent Health Chief Executive Officer Seth Blackley on Glassdoor.com. Seth Blackley has an approval rating of 100% among the company's employees. This puts Seth Blackley in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Evolent Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Evolent Health investors own include CA (CA), BlackRock (BLK), Universal Insurance (UVE), Endologix (ELGX), Advanced Micro Devices (AMD), Energy Transfer (ET), Chipotle Mexican Grill (CMG), Ford Motor (F), Cisco Systems (CSCO) and Heron Therapeutics (HRTX).

When did Evolent Health IPO?

(EVH) raised $150 million in an initial public offering (IPO) on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs served as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

Who are Evolent Health's major shareholders?

Evolent Health's stock is owned by many different retail and institutional investors. Top institutional investors include FMR LLC (14.35%), Rock Springs Capital Management LP (3.36%), RA Capital Management L.P. (2.38%), Eventide Asset Management LLC (2.30%), William Blair Investment Management LLC (2.32%) and Loomis Sayles & Co. L P (1.81%). Insiders that own company stock include Cheryl Scott, Daniel Joseph Mccarthy, Diane Holder, Frank J Williams, Frank J Williams, John Paul Johnson, Jonathan Weinberg, Mary Bridget Duffy, Seth Blackley, Simon Maisey and Steve Tutewohl.
View institutional ownership trends
.

How do I buy shares of Evolent Health?

Shares of EVH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:EVH) was last updated on 12/1/2023 by MarketBeat.com Staff

My Account -